These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hair graying and loss induced by imatinib mesylate. Yun SK; Song KH; Hwang SR; Kim HU; Lee NR; Park J J Dermatol; 2014 Jan; 41(1):107-8. PubMed ID: 24354806 [No Abstract] [Full Text] [Related]
5. Intolerance to imatinib in gastrointestinal stromal tumors: a case report and a review of literature. Akasbi Y; Arifi S; Brahmi SA; El Mrabet FZ; Mellas N; Mernisi FZ; El Mesbahi O J Gastrointest Cancer; 2014 Dec; 45 Suppl 1():71-3. PubMed ID: 24006243 [No Abstract] [Full Text] [Related]
6. Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia. Machaczka M; Gossart M Pol Arch Med Wewn; 2013; 123(5):251-2. PubMed ID: 23722191 [No Abstract] [Full Text] [Related]
7. Cutaneous lichenoid eruption caused by imatinib mesylate in a Japanese patient with chronic myeloid leukaemia. Kawakami T; Kawanabe T; Soma Y Acta Derm Venereol; 2009; 89(3):325-6. PubMed ID: 19479144 [No Abstract] [Full Text] [Related]
8. Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor. Yeh CN; Fu CJ; Yen TC; Chiang KC; Jan YY; Chen MF J Clin Oncol; 2013 Jun; 31(16):e248-50. PubMed ID: 23569321 [No Abstract] [Full Text] [Related]
9. Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate. Lau YM; Lam YK; Leung KH; Lin SY Hong Kong Med J; 2014 Oct; 20(5):464.e2. PubMed ID: 25307080 [No Abstract] [Full Text] [Related]
10. Lichenoid eruption due to imatinib. Prabhash K; Doval DC Indian J Dermatol Venereol Leprol; 2005; 71(4):287-8. PubMed ID: 16394444 [No Abstract] [Full Text] [Related]
11. Imatinib-induced anasarca without heart failure: capillary leakage? Sendur MA; Aksoy S; Civelek B; Zengin N J BUON; 2012; 17(1):188-9. PubMed ID: 22517720 [No Abstract] [Full Text] [Related]
12. Oral lichenoid eruption secondary to imatinib (Glivec). Ena P; Chiarolini F; Siddi GM; Cossu A J Dermatolog Treat; 2004 Jul; 15(4):253-5. PubMed ID: 15764042 [TBL] [Abstract][Full Text] [Related]
13. Early onset imatinib mesylate-induced hepatotoxicity in a patient with gastrointestinal stromal tumors. Yachoui R Am J Ther; 2014; 21(5):e148-50. PubMed ID: 23567788 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous hemoperitoneum in recurrent jejunal gastrointestinal stromal tumor after imatinib therapy. Yin TC; Fan WC; Huang CJ; Hsieh JS Kaohsiung J Med Sci; 2013 Jul; 29(7):402-3. PubMed ID: 23768706 [No Abstract] [Full Text] [Related]
18. Lichenoid drug eruption related to imatinib: report of a new case and review of the literature. Sendagorta E; Herranz P; Feito M; Ramírez P; Feltes R; Floristán U; Mariño-Enriquez A; Casado M Clin Exp Dermatol; 2009 Oct; 34(7):e315-6. PubMed ID: 19456782 [No Abstract] [Full Text] [Related]
19. Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor. Enck RE; Abushahin F; Bossaer JB J Oncol Pharm Pract; 2014 Apr; 20(2):137-40. PubMed ID: 23676509 [TBL] [Abstract][Full Text] [Related]
20. Oral lichenoid eruption associated with imatinib treatment. Gómez Fernández C; Sendagorta Cudós E; Casado Verrier B; Feito Rodríguez M; Suárez Aguado J; Vidaurrázaga Díaz de Arcaya C Eur J Dermatol; 2010; 20(1):127-8. PubMed ID: 19825526 [No Abstract] [Full Text] [Related] [Next] [New Search]